Clinical Trial Update: A Bioequivalence Study of Two Different Processes of PEG-rhGH Preparations [Phase 1]

View source ↗

Summary

This document reports a Phase 1 bioequivalence study comparing two production processes for PEG-rhGH and involves pediatric growth hormone deficiency; the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• PEG-rhGH (pegylated recombinant human growth hormone)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Pediatric Growth Hormone Deficiency (PGHD) | Phase 1 | Status: NOT_YET_RECRUITING